Download PDF
1 / Pages

Other users also viewed these articles

The epidemiology of non-alcoholic steatohepatitis (NASH) in the United States between 2010-2020: a population-based study Osama Hamid; Ahmed Eltelbany; Abdul Mohammed; Khaled Alsabbagh Alchirazi; Sushrut Trakroo; Imad Asaad;
Ann Hepatol. 2022;27:
Insulin resistance and Metabolic dysfunction-associated steatotic liver disease (MASLD): Pathways of action of hypoglycemic agents Andrea del Carmen Maldonado-Rojas; Julia María Zuarth-Vázquez; Misael Uribe; Varenka J Barbero-Becerra;
Ann Hepatol. 2024;29:
Prevalence of non-alcoholic fatty liver disease and liver fibrosis in a general population cohort from Argentina Federico Guillermo Villamil; Manuel Barbero; Nancy Elena Massenzio; Sandra Mónica Giani; Shigeru Kozima; Fernando Mario Cairo; Rodrigo Agustín Belloni; Javier Mariani; Mercedes Rodriguez Gazari; Paola Evangelina Coisson; Sonia Carolina Gallardo; Paula Andrea Cocco; Claudia Mabel Riboldi; Patricia Eugenia Gallardo;
Ann Hepatol. 2023;28: